2-[[4-氨基-1-[5-(1-氨基-2-羟丙基)-1,3,4-恶二唑-2-基]-4-氧代丁基]氨基甲酰基氨基]-3-羟基丙酸(1673560-66-1)名称与标识符
名称
中文别名：
(S)-2-(3-((S)-4-氨基-1-(5-((1S,2R)-1-氨基-2-羟丙基)-1,3,4-恶二唑-2-基)-4-氧代丁基)脲基)-3-羟基丙酸;
英文别名：
PD1-IN-1;BCP31132;2-[[4-Amino-1-[5-(1-amino-2-hydroxypropyl)-1,3,4-oxadiazol-2-yl]-4-oxobutyl]carbamoylamino]-3-hydrox;PD-1-IN-17;(S)-2-(3-((S)-4-Amino-1-(5-((1S,2R)-1-amino-2-hydroxypropyl)-1,3,4-oxadiazol-2-yl)-4-oxobutyl)ureido)-3-hydroxypropanoic acid;1673560-66-1;EX-A4358;DA-56651;SCHEMBL19450456;CHEMBL4458504;AKOS040733979;AC-37062;MS-26046;PD-1-IN-17 free base;HY-101097;G16430;(2S)-2-[[(1S)-4-amino-1-[5-[(1S,2R)-1-amino-2-hydroxypropyl]-1,3,4-oxadiazol-2-yl]-4-oxobutyl]carbamoylamino]-3-hydroxypropanoic acid;CS-0020822;PD-1-IN-17?;
标识符
InChIKey：
SRNQPYBWRIETFQ-UHFFFAOYSA-N
Inchi：
1S/C13H22N6O7/c1-5(21)9(15)11-19-18-10(26-11)6(2-3-8(14)22)16-13(25)17-7(4-20)12(23)24/h5-7,9,20-21H,2-4,15H2,1H3,(H2,14,22)(H,23,24)(H2,16,17,25)
SMILES：
O1C(C([H])(C([H])(C([H])([H])[H])O[H])N([H])[H])=NN=C1C([H])(C([H])([H])C([H])([H])C(N([H])[H])=O)N([H])C(N([H])C([H])(C(=O)O[H])C([H])([H])O[H])=O
3007955256 
![2-[[4-氨基-1-[5-(1-氨基-2-羟丙基)-1,3,4-恶二唑-2-基]-4-氧代丁基]氨基甲酰基氨基]-3-羟基丙酸结构式图片|1673560-66-1结构式图片](http://hg.y866.cn/compound/lib/scimg/cas/150/1673560-66-1.png?t=638986984055273038)
